Evidence map›Paper›PMID 24603711›Full record

ArticlePloS one2014

Characterisation of leukocytes in a human skin blister model of acute inflammation and resolution.

William Jenner, Madhur Motwani, Kristin Veighey, Justine Newson, Tatsiana Audzevich, Anna Nicolaou, Sharon Murphy, Raymond Macallister, Derek W Gilroy

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 32 citations in OpenAlex.

  1. Trial
  2. Macrophage heterogeneity in human secondary lymphoid organs.Clinical science (London, England : 1979) · 2026
    Review
  3. Review
  4. Efferocytosis in Homeostasis.Advances in experimental medicine and biology · 2025
    Review
  5. Review
  6. Article
  7. Article
  8. Observational
  9. Review
  10. Article
  11. Innate immune cell-epithelial crosstalk during wound repair.The Journal of clinical investigation · 2019
    Review
  12. Article
  13. Frontiers in immunology · 2019
    Review
  14. Article
  15. Review
  16. Article
  17. Resolution of inflammation: a new therapeutic frontier.Nature reviews. Drug discovery · 2016
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

William JennerCentre for Clinical Pharmacology and Therapeutics, Division of Medicine, University College London, London, United Kingdom.
Madhur MotwaniCentre for Clinical Pharmacology and Therapeutics, Division of Medicine, University College London, London, United Kingdom.
Kristin VeigheyCentre for Clinical Pharmacology and Therapeutics, Division of Medicine, University College London, London, United Kingdom.
Justine NewsonCentre for Clinical Pharmacology and Therapeutics, Division of Medicine, University College London, London, United Kingdom.
Tatsiana AudzevichCentre for Clinical Pharmacology and Therapeutics, Division of Medicine, University College London, London, United Kingdom.
Anna NicolaouManchester Pharmacy School, Faculty of Medical and Human Sciences, University of Manchester, Manchester, United Kingdom.
Sharon MurphyManchester Pharmacy School, Faculty of Medical and Human Sciences, University of Manchester, Manchester, United Kingdom.
Raymond MacallisterCentre for Clinical Pharmacology and Therapeutics, Division of Medicine, University College London, London, United Kingdom.
Derek W GilroyCentre for Clinical Pharmacology and Therapeutics, Division of Medicine, University College London, London, United Kingdom.
University College London · GBUniversity of Manchester · GB

Funding

British Heart Foundation FS/10/44/28294Wellcome Trust 087520
6 · The paper itself

Abstract

There is an increasing need to understand the leukocytes and soluble mediators that drive acute inflammation and bring about its resolution in humans. We therefore carried out an extensive characterisation of the cantharidin skin blister model in healthy male volunteers. A novel fluorescence staining protocol was designed and implemented, which facilitated the identification of cell populations by flow cytometry. We observed that at the onset phase, 24 h after blister formation, the predominant cells were CD16hi/CD66b+ PMNs followed by HLA-DR+/CD14+ monocytes/macrophages, CD11c+ and CD141+ dendritic cells as well as Siglec-8+ eosinophils. CD3+ T cells, CD19+ B cells and CD56+ NK cells were also present, but in comparatively fewer numbers. During resolution, 72 h following blister induction, numbers of PMNs declined whilst the numbers of monocyte/macrophages remain unchanged, though they upregulated expression of CD16 and CD163. In contrast, the overall numbers of dendritic cells and Siglec-8+ eosinophils increased. Post hoc analysis of these data revealed that of the inflammatory cytokines measured, TNF-α but not IL-1β or IL-8 correlated with increased PMN numbers at the onset. Volunteers with the greatest PMN infiltration at onset displayed the fastest clearance rates for these cells at resolution. Collectively, these data provide insight into the cells that occupy acute resolving blister in humans, the soluble mediators that may control their influx as well as the phenotype of mononuclear phagocytes that predominate the resolution phase. Further use of this model will improve our understanding of the evolution and resolution of inflammation in humans, how defects in these over-lapping pathways may contribute to the variability in disease longevity/chronicity, and lends itself to the screen of putative anti-inflammatory or pro-resolution therapies.

Indexed as

AdolescentAdultAntigens, CD19BlisterB-LymphocytesCD3 ComplexCD56 AntigenCytokinesDendritic CellsEosinophilsFlow CytometryHumansInflammationKiller Cells, NaturalLeukocyte CountLeukocytesAntigens, CD19CD3 ComplexCD56 AntigenCytokines

Identifiers

PMID24603711
PMCPMC3945731
OpenAlexW1973003732

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.